<DOC>
	<DOC>NCT00072865</DOC>
	<brief_summary>This is a nonrandomized study of pemetrexed plus carboplatin, with the primary objective of determining the efficacy of the combination in tumor reduction, in patients with locally advanced or metastatic breast cancer.</brief_summary>
	<brief_title>Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Histologic or cytologic diagnosis of locally advanced or metastatic breast cancer No prior chemotherapy for locally advanced or metastatic breast disease. Patient may have received prior adjuvant therapy finished greater than 1 year prior to enrollment. Adequate bone marrow, liver and kidney function RECIST criteria for disease status Prior treatment with pemetrexed Pregnant or breast feeding Brain Metastasis unable or unwilling to take folic acid, vitamin B12 supplementation, or dexamethasone.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>